Innovative cutting-edge technology has refurbished the healthcare sector on a massive scale providing the healthcare service providers with a chance to offer more improved personalized service to the patients in an efficient, cost-effective, and personalized way. Diverse innovations are still being made to develop advanced apparatus to solve the complicated prevailing issues related to public health.
These days, cardiovascular diseases or CVDs have become real threats to intimidate the patients and the healthcare service providers. WHO says, 17.9 million people died of CVDs. So, from hospital products to wearables to measure blood pressure, several discoveries have been made to combat it. Out-of-hospital cardiac arrests have assumed more diabolic dimensions because often, in such cases patients do not receive proper medication or die of wrong treatment.
The American Heart Association and Laerdal Medical have undertaken a joint venture partnership to revolutionize the U.S. healthcare sector through the production of advanced resuscitation solutions. They have recently introduced RQI 2020 to provide improved CPR quality at a lower cost. The joint venture, RQI Partners, LLC aims at integrating the American Heart Association's scientific knowledge and Laerdal Medical's technology to build solutions to facilitate the process of resuscitation.
The RQI 2020 is an essential addition to the product portfolio of the company which empowers all healthcare staffs including the non-clinical members to offer high-quality CPR, necessary life support, and pediatric advanced life support leveraging e-learning simulations. This innovative device monitors, records, and provides feedback in real-time for every learner's performance through the learning management technology, and can update itself automatically to provide advanced scientific knowledge. Undoubtedly, these learning programs are inherently essential to eradicate the problems related to wrong treatment. Currently, more than 400 U.S. hospitals take resort to the RQI program to provide more improved service as the implementation of this simulation-based platform can be made through low-dose. Under this joint venture, the companies have undertaken more new programs like the RQI Telecommunicator which offers PSAPs the chance to have quality, ongoing learning, and quality improvement review related to the management of sudden cardiac arrest. The Cardiac Arrest System Assessment is another innovative program which can open up a conversation within the EMS system to point out the areas of improvement during an OHCA.